Concourse Financial Group Securities’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 635 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2719 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2713 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2757 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2772 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2730 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2746 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2754 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2755 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2698 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2474 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2570 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2531 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2712 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2729 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2674 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2630 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2576 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2439 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2349 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2424 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2347 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2046 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2469 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2482 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2351 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1885 |
|